Incorporation and washout of orally administered n-3 fatty acid ethyl esters in different plasma lipid fractions. 1999

S D Zuijdgeest-van Leeuwen, and P C Dagnelie, and T Rietveld, and J W van den Berg, and J H Wilson
Institute of Internal Medicine II, Erasmus University of Rotterdam, The Netherlands.

The aim of the present study was to quantify the incorporation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) into plasma lipids after oral administration of n-3 fatty acid ethyl esters, since little is known about the rate and pattern of incorporation into plasma lipid fractions. In addition, we aimed to obtain preliminary information regarding EPA half-life, which is needed to establish an optimal dosing schedule. Five healthy volunteers ingested two 8.5 g doses of n-3 fatty acid ethyl esters daily for 7 d, supplying 6.0 g EPA/d and 5.3 g DHA/d. The fatty acid compositions of plasma phospholipids (PL), cholesteryl esters (CE) and triacylglycerols (TAG) were determined during supplementation and during a washout period of 7 d. Half-lives of EPA and DHA were calculated. The proportion of EPA in PL showed a 15-fold increase after 7 d (P < 0.001), while DHA showed a smaller increase (P < 0.01). In CE, EPA also increased (P < 0.05), while DHA did not increase at all. Remarkably, incorporation of DHA into TAG was even higher than that of EPA. Half-life of EPA in PL ranged from 1.63 to 2.31 d (mean 1.97 (SE 0.15) d), whereas mean half-life of EPA in CE was 3.27 (SE 0.56) d. In three subjects, washout of EPA and DHA from TAG seemed to follow a bi-exponential pattern, with a short half-life (< 1 d) in the initial phase and a half-life of several days in the second phase. In conclusion, EPA ethyl esters are rapidly incorporated into plasma lipids, especially into PL. The relatively long half-life of EPA in plasma would permit a dosing schedule with intervals of > or = 12 h in supplementation studies.

UI MeSH Term Description Entries
D008297 Male Males
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D002788 Cholesterol Esters Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis. Cholesterol Ester,Cholesteryl Ester,Cholesteryl Esters,Ester, Cholesterol,Ester, Cholesteryl,Esters, Cholesterol,Esters, Cholesteryl
D004281 Docosahexaenoic Acids C22-unsaturated fatty acids found predominantly in FISH OILS. Docosahexaenoate,Docosahexaenoic Acid,Docosahexenoic Acids,Docosahexaenoic Acid (All-Z Isomer),Docosahexaenoic Acid Dimer (All-Z Isomer),Docosahexaenoic Acid, 3,6,9,12,15,18-Isomer,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer),Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cerium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cesium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Potassium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer),Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer,Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer, Sodium Salt,Docosahexaenoic Acid, Sodium Salt,Acid, Docosahexaenoic,Acids, Docosahexaenoic,Acids, Docosahexenoic
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses

Related Publications

S D Zuijdgeest-van Leeuwen, and P C Dagnelie, and T Rietveld, and J W van den Berg, and J H Wilson
December 2015, Regulatory toxicology and pharmacology : RTP,
S D Zuijdgeest-van Leeuwen, and P C Dagnelie, and T Rietveld, and J W van den Berg, and J H Wilson
December 1994, European journal of clinical nutrition,
S D Zuijdgeest-van Leeuwen, and P C Dagnelie, and T Rietveld, and J W van den Berg, and J H Wilson
January 1994, World review of nutrition and dietetics,
S D Zuijdgeest-van Leeuwen, and P C Dagnelie, and T Rietveld, and J W van den Berg, and J H Wilson
August 1993, Journal of lipid research,
S D Zuijdgeest-van Leeuwen, and P C Dagnelie, and T Rietveld, and J W van den Berg, and J H Wilson
November 1998, Poultry science,
S D Zuijdgeest-van Leeuwen, and P C Dagnelie, and T Rietveld, and J W van den Berg, and J H Wilson
January 1977, Advances in experimental medicine and biology,
S D Zuijdgeest-van Leeuwen, and P C Dagnelie, and T Rietveld, and J W van den Berg, and J H Wilson
January 1998, Voprosy pitaniia,
S D Zuijdgeest-van Leeuwen, and P C Dagnelie, and T Rietveld, and J W van den Berg, and J H Wilson
October 1998, Lipids,
S D Zuijdgeest-van Leeuwen, and P C Dagnelie, and T Rietveld, and J W van den Berg, and J H Wilson
December 2009, The Physician and sportsmedicine,
S D Zuijdgeest-van Leeuwen, and P C Dagnelie, and T Rietveld, and J W van den Berg, and J H Wilson
September 2007, Journal of cardiovascular medicine (Hagerstown, Md.),
Copied contents to your clipboard!